Catalyst Wire Dossier Catalyst Wire Dossier

RSS0343

· Jiangsu HengRui Medicine Co., Ltd.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for RSS0343, covering 2025-05-13 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of RSS0343 Tablets in Patients With Chronic Obstructive Pulmonary Disease [Phase 2]

See pricing